Analysis of Demographic Characteristics and Treatment Outcome of Breast Cancer Patients in a Tertiary Cancer Centre

Velappan, Arumugam; Shumugam, Deepa

doi:10.9790/0853-1605092528

Cited by 3 publications

(2 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…On other hand about 12.8% of our patients had family history of breast cancer. This lower than previous studies in Iraq (18.7%) Turkey (15.8%) but it is higher than in India (4.2%) [22,[34][35].…”

Section: Barriers For Early Diagnosiscontrasting

confidence: 68%

Breast Cancer in Middle Euphrates Region of Iraq: Risk Factors, Presenting Symptoms and Time to Medical Help-Seeking

Mjali¹,

Jawad²,

Al-Shammari³

2021

Asian Pac J Cancer Care

View full text Add to dashboard Cite

Background: Breast cancer is the most frequently occurring tumor and the first cause of death in females. Low level of understanding early symptoms leads to a late diagnosis and high mortality rates. Aims: To describe presenting symptoms, risk factors, and medical care delays among breast cancer patients in Iraq. Materials & Methods: A retrospective, descriptive study conducted in Al-Hussein center in Karbala province of Iraq between February 2012 and August 2020.Results: There were 101 female patients with breast cancer, median age was 45 years. Most of our patients diagnosed incidentally and only 17.82% of our patients were performing breast self examination. Lack of physical activity was the most common risk factors in more than 74% of patients. Painless breast lump was the most frequent symptom in 85.14% of patients. Majority of our patients 58.42% asked medical help within six months. Limited knowledge about symptoms was the common barriers for early diagnosis in 43.94% of patients. Conclusion: Lack of knowledge about breast cancer had a major concern in our region. Increasing awareness about early symptoms and risk factors is very important for early diagnosis and proper management.

show abstract

Section: Barriers For Early Diagnosiscontrasting

confidence: 68%

Breast Cancer in Middle Euphrates Region of Iraq: Risk Factors, Presenting Symptoms and Time to Medical Help-Seeking

Mjali¹,

Jawad²,

Al-Shammari³

2021

Asian Pac J Cancer Care

View full text Add to dashboard Cite

show abstract

“…31 In India, the median age at presentation in a survey including 1528 breast cancer patients was 49 years, 69.6% were postmenopausal, family history of breast cancer was positive in 4.2%, the most common symptom was palpable lumps (96%) and 57% were diagnosed in stages III and IV disease. 32 On the other hand, in Croatia, Europe, where breast cancer is the most common type of female malignancy, analysis of the demographic characteristics and reproductive findings belonging to 870 female patients showed that the mean age was 69 years; <2% were younger than 35 years. 33 These findings were consistent with the results reported in other European studies.…”

Section: Discussionmentioning

confidence: 99%

Demographic and clinical profiles of female patients diagnosed with breast cancer in Iraq

Alwan

Tawfeeq

Mallah

2019

J. Contemp. Med. Sci.

View full text Add to dashboard Cite

Objective To highlight the main demographic characteristics and clinical profiles of female patients registered with breast cancer in Iraq; focusing on the impact of age.Methods This retrospective study enrolled 1172 female patients who were diagnosed with breast cancer at the Main Center for Early Detection of Breast Cancer/Medical City Teaching Hospital in Baghdad. Data were extracted from an established information system, developed by the principal author under supervision of WHO, that was based on valid clinical records of Iraqi patients affected by breast cancer. The recorded information regarding clinical examination comprised positive palpable lumps, bloody nipple discharge, skin changes, bilateral breast involvement, tumor size, lymph node status, and the stage of the disease.Results The mean age at the presentation was 51 years; patients under the age of 50 constituted 46.8%. Overall 9.8% were not married, 22.4% were illiterate whereas 19.2% graduated from universities. About 72% of the patients had more than two children, merely 7.5% delivered their first child after the age of 35 years and only 11% were nulliparous. History of lactation and hormonal therapy was recorded in 57.6% and 19.4% respectively. Family history of cancer was positive in 28.8% and breast cancer specifically in 18.7%. Clinically, the most common presenting symptom was breast lumps (95%) followed by skin changes/ulcerations (6.7%) and bloody nipple discharge (4.3%).Bilateral breast involvement was encountered in 4.7%. More than two-thirds of the patients (68.2%) had palpable axillary lymph nodes; classifying 40.5% into advanced stages III and IV. In general stages Iâ€“IV comprised 12%, 47.5%, 31.9%, and 8.6% respectively. Upon stratifying the studied sample with respect to age at diagnosis, it was observed that the frequency of unmarried patients was significantly higher among younger women under the age of 50 years, whereas illiteracy and nulliparity features were statistically lower (p < 0.05).Conclusion A considerable proportion of breast cancer patients in Iraq still present with locally advanced disease at the time of diagnosis. That justifies the necessity to promote public awareness educational campaigns to strengthen our national early detection program. Excluding the marital status, level of education and number of parity, there was no statistical difference regarding the impact of age on the demographic and clinical profiles of breast cancer among premenopausal versus postmenopausal Iraqi patients.

show abstract

Patterns of Failure and Survival in Er/Pr Positive Carcinoma Breast With Conventional Versus Extended Hormonal Therapy.

Priya

Priya²,

Sharma³

2022

ijsr

View full text Add to dashboard Cite

Breast cancer is the second most common cancer in the world. Globally over the last several decades, the incidence of breast cancer has increased and the greatest increase has been seen in Asian countries and women in their 40s are affected mostly. Adjuvant Endocrine therapy is highly effective and appropriate for nearly all women with Estrogen Receptor- and/or Progesterone positive tumors, making such treatment the most widely prescribed therapy for patients with cancer in both the developed and developing countries. The present study aimed to compare the pattern of failure and survival in Estrogen Receptor/Progesterone Receptor positive Carcinoma Breast with conventional i.e. patients who have received hormonal therapy for 5 years versus extended hormonal therapy i.e patients who have received hormonal therapy for more than 5 years. Assessing short & long term effects prole of these hormonal regime. The present retro-prospective study was conducted in a multidisciplinary Tertiary care hospital in Srinagar, over a period of 2 years (August 2016 to August 2018) and a total of 105 patients were included in the study. It was observed in the study that mean age of study participants was 46.5±8.55 years in group A, and 43.2±7.31 years in group B and majority (40.95%) of the participants were in the age group 40-49 years. In Group- A, 23 patients belonged to Urban and 28 belonged to Rural whereas in Group-B, 38 subjects belonged to Urban areas and 16 from rural area. It was concluded in the study that patients who are on extended hormonal therapy had overall high survival 5.71% in comparison to conventional therapy i.e., 1.96%.

show abstract

Analysis of Demographic Characteristics and Treatment Outcome of Breast Cancer Patients in a Tertiary Cancer Centre

Cited by 3 publications

References 12 publications

Breast Cancer in Middle Euphrates Region of Iraq: Risk Factors, Presenting Symptoms and Time to Medical Help-Seeking

Breast Cancer in Middle Euphrates Region of Iraq: Risk Factors, Presenting Symptoms and Time to Medical Help-Seeking

Demographic and clinical profiles of female patients diagnosed with breast cancer in Iraq

Patterns of Failure and Survival in Er/Pr Positive Carcinoma Breast With Conventional Versus Extended Hormonal Therapy.

Contact Info

Product

Resources

About